These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15183792)

  • 1. Chronic central serous chorioretinopathy: photodynamic therapy.
    Taban M; Boyer DS; Thomas EL; Taban M
    Am J Ophthalmol; 2004 Jun; 137(6):1073-80. PubMed ID: 15183792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
    Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
    Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
    Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy.
    Ober MD; Yannuzzi LA; Do DV; Spaide RF; Bressler NM; Jampol LM; Angelilli A; Eandi CM; Lyon AT
    Ophthalmology; 2005 Dec; 112(12):2088-94. PubMed ID: 16325707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy for central serous chorioretinopathy using a reduced dose of verteporfin.
    Williams MA; Mulholland C; Silvestri G
    Can J Ophthalmol; 2008 Feb; 43(1):123. PubMed ID: 18219357
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
    Chan WM; Lai TY; Lai RY; Tang EW; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.
    Yannuzzi LA; Slakter JS; Gross NE; Spaide RF; Costa D; Huang SJ; Klancnik JM; Aizman A
    Retina; 2003 Jun; 23(3):288-98. PubMed ID: 12824827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
    Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy in chronic central serous chorioretinopathy.
    Battaglia Parodi M; Da Pozzo S; Ravalico G
    Retina; 2003 Apr; 23(2):235-7. PubMed ID: 12707605
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
    Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M
    Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy.
    Fujita K; Imamura Y; Shinoda K; Matsumoto CS; Mizutani Y; Mizota A; Yuzawa M
    Retina; 2014 May; 34(5):964-70. PubMed ID: 24406387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathy.
    Lim JI; Glassman AR; Aiello LP; Chakravarthy U; Flaxel CJ; Spaide RF;
    Ophthalmology; 2014 May; 121(5):1073-8. PubMed ID: 24439758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy.
    Nicolò M; Zoli D; Musolino M; Traverso CE
    Am J Ophthalmol; 2012 Mar; 153(3):474-480.e1. PubMed ID: 22019224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
    Moon JW; Yu HG; Kim TW; Kim HC; Chung H
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1315-23. PubMed ID: 19421764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future role of photodynamic therapy in chronic central serous chorioretinopathy.
    Azad RV; Rani A; Pal N; Chandra P; Sharma YR
    Am J Ophthalmol; 2005 Feb; 139(2):393-4; author reply 394. PubMed ID: 15734027
    [No Abstract]   [Full Text] [Related]  

  • 17. A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.
    Zhao M; Zhang F; Chen Y; Dai H; Qu J; Dong C; Kang X; Liu Y; Yang L; Li Y; Zhou P; Pan CT; Zhang L; Liu P; Zhou H; Jiao X; Xiong Y; Tian R; Lu Y; Yu X; Li X
    JAMA Ophthalmol; 2015 Mar; 133(3):333-40. PubMed ID: 25555191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
    Koytak A; Erol K; Coskun E; Asik N; Öztürk H; Özertürk Y
    Retina; 2010; 30(10):1698-703. PubMed ID: 20539254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy for chronic central serous chorioretinopathy.
    Ruiz-Moreno JM; Lugo FL; Armadá F; Silva R; Montero JA; Arevalo JF; Arias L; Gómez-Ulla F
    Acta Ophthalmol; 2010 May; 88(3):371-6. PubMed ID: 19958296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMPARISON OF HALVING THE IRRADIATION TIME OR THE VERTEPORFIN DOSE IN PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Shiode Y; Morizane Y; Kimura S; Hosokawa M; Kawata T; Doi S; Hosogi M; Fujiwara A; Shiraga F
    Retina; 2015 Dec; 35(12):2498-504. PubMed ID: 26035398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.